「Soluble Programmed Cell Death Ligand 1 as a Novel Biomarker for Nivolumab Therapy for Non-Small-cell Lung Cancer」の関連論文
-
The ATR inhibitor AZD6738 increases the sensitivity of 5-fluorouracil in colorectal cancer cells by abrogating repair of DNA damage
-
CDK8/19 inhibition plays an important role in pancreatic β-cell induction from human iPSCs
-
A novel cancer immunotherapy using tumor-infiltrating B cells in the APC (min/+) mouse model
-
B cell depletion with anti-CD20 mAb exacerbates anti-donor CD4+ T cell responses in highly sensitized transplant recipients
-
B cell depletion with anti-CD20 mAb exacerbates anti-donor CD4+ T cell responses in highly sensitized transplant recipients
-
miR-26a regulates extracellular vesicle secretion from prostate cancer cells via targeting SHC4, PFDN4, and CHORDC1
-
Oncolytic activity of naturally attenuated herpes-simplex virus HF10 against an immunocompetent model of oral carcinoma
-
Cell therapy for Parkinson's disease with induced pluripotent stem cells
-
Efficacious Combination Drug Treatment for Colorectal Cancer that Overcomes Resistance to KRAS G12C Inhibitors
-
Circulating microRNA/isomiRs as novel biomarkers of esophageal squamous cell carcinoma
-
Circulating microRNA/isomiRs as novel biomarkers of esophageal squamous cell carcinoma
-
MicroRNA profiles following telmisartan treatment in pancreatic ductal adenocarcinoma cells
-
Yes-associated protein 1 mediates initial cell survival during lorlatinib treatment through AKT signaling in ROS1-rearranged lung cancer
-
Overexpression of aldolase, fructose-bisphosphate C and its association with spheroid formation in colorectal cancer
-
Overexpression of aldolase, fructose-bisphosphate C and its association with spheroid formation in colorectal cancer
-
Suppression of malignant rhabdoid tumors through Chb-M′-mediated RUNX1 inhibition
-
Identification and characterization of slow‑cycling cells in Ewing sarcoma
-
Serum IgG level is a predicting factor for the response to neoadjuvant chemotherapy in patients with esophageal squamous cell carcinoma
-
Construction of a single-cell atlas of non-hematopoietic cells in human lymph nodes and lymphoma for dissecting stromal remodeling
-
The lectin-like domain of thrombomodulin is a drug candidate for both prophylaxis and treatment of liver ischemia and reperfusion injury in mice
-
Identification of an Anti-Integrin αvβ6 Autoantibody in Patients With Ulcerative Colitis
-
Studies on programmed death-ligand 1 in equine and swine diseases [an abstract of entire text]
-
Heat shock protein 105 peptide vaccine could induce antitumor immune reactions in a phase I clinical trial
-
Re-generation of cytotoxic γδT cells with distinctive signatures from human γδT-derived iPSCs
-
Comprehensive analysis of circulating microRNAs as predictive biomarkers for sorafenib therapy outcome in hepatocellular carcinoma
-
Studies on Peripheral Blood mMDSC Based-Biomarker Exploration and a Novel Therapeutic Agent for Cancer Immunotherapy
-
Mutation burden-orthogonal tumor genomic subtypes delineate responses to immune checkpoint therapy
-
Propofol elicits apoptosis and attenuates cell growth in esophageal cancer cell lines
-
Non-Genetic Cell-Surface Modification with a Self-Assembling Molecular Glue
-
Inhibition of heat shock protein 90 destabilizes receptor tyrosine kinase ROR1 in lung adenocarcinoma
-
Investigation of the mechanism for emergence of spatial heterogeneity of invading glioblastoma cells in the presence of perivascular factors (本文)
-
Development of a novel cancer therapy with a ferroptosis inducer and radiation, and a prediction method for therapeutic effects targeting ferroptosis
-
Enhanced G1 arrest and apoptosis via MDM4/MDM2 double knockdown and MEK inhibition in wild-type TP53 colon and gastric cancer cells with aberrant KRAS signaling
-
Cutaneous T-cell-attracting chemokine as a novel biomarker for predicting prognosis of idiopathic pulmonary fibrosis: a prospective observational study
-
Gold Nanoparticles Enhance the Tumor Growth-Suppressing Effects of Cetuximab and Radiotherapy in Head and Neck Cancer In Vitro and In Vivo
-
Profiling of Naquotinib, a Small Molecule Kinase Inhibitor, as EGFR and BTK Inhibitor
-
Efficacy of the Novel Tubulin Polymerization Inhibitor PTC-028 for Myelodysplastic Syndrome
-
Brg1 is required to maintain colorectal cancer stem cells
-
De Novo T790M Mutation in an L858R Epidermal Growth Factor Receptor Mutant-Associated Lung Adenocarcinoma
-
Automated measurement of fluorescence signals reveals a significant increase of the graft-derived neurite extension in neonates compared to aged rats
-
FE65 in breast cancer: its clinicopathological and biological significance
-
In silico study of RNA-seq and H3 Trimethylation ChIP-seq analysis in combination with laser-microdissection on human lung cancer cells
-
Identification of cisplatin-resistant factor by integration of transcriptomic and proteomic data using head and neck carcinoma cell lines
-
CXCL2 combined with HVJ-E suppresses tumor growth and lung metastasis in breast cancer and enhances anti-PD-1 antibody therapy
-
CD204‑positive macrophages accumulate in breast cancer tumors with high levels of infiltrating lymphocytes and programmed death ligand‑1 expression
-
Development of an in vitro carcinogenesis model of human papillomavirus-induced cervical adenocarcinoma (本文)
-
Involvement of Corticotropin-releasing Hormone-related Peptides in Cellular Stress Caused by Anticancer Drugs in Colorectal Cancer
-
Lenvatinib-induced severe generalized erythematous rash in a patient with hepatocellular carcinoma
-
転移性尿路上皮癌に対するGC療法における, Gemcitabine投与後の発熱の臨床的意義の検討: 多施設共同後ろ向き研究
-
Antifibrotic effect of lung-resident progenitor cells with high aldehyde dehydrogenase activity